Pharmacy Podcast Network

Continuous Glucose Monitoring:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes in Diabetes Management  
Objectives 
Describe the use of continuous glucose monitoring (CGM) in diabetes management and ADA/AACE recommendations
Recognize the role of the pharmacist in providing education related to the use of CGM devices and interpreting CGM data
Faculty Disclosures
Curtis L. Triplitt, PharmD, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Bayer
Speaker’s Bureau: Eli Lilly, NovoNordisk
Susan Cornell, PharmD, CDCES, FAPhA, FADCES, has the following relevant financial relationships with commercial interests to disclose:
Speaker’s Bureau: Novo Nordisk, Inc.
Other Support: Advanced Practitioner Advisory Board- Novo Nordisk, Inc.
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for .5 contact hours of knowledge-based credit.
This activity is supported by an independent educational grant from Abbott Diabetes Care Inc.
Learn more here: https://www.pharmacytimes.org/on-demand/continuous-glucose-monitoring-understanding-the-pharmacists-role-in-patient-education-and-improving-outcomes-in-diabetes-management
Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The UnScripted Podcast, episode one is a conversation with Cecelia Byers, PharmD Specialty Pharmacy Clinical Product Manager and Dr. Andrew Mellin, VP, Chief Medical Information Officer with Surescripts. Today we have a interesting discussion on how the process of prescribing and dispensing specialty medication relies on antiquated technology: fax machines, paper forms and phone calls and how Surescripts is transforming the process for prescribing specialty medications Learn more: https://surescripts.com/resources/specialty-medications This podcast is a call to action on the broader healthcare industry to standardize digital processes to help remove admin burden We talk about the need for system-wide streamlining of data between providers, patients, and pharmacies not only to ensure all the necessary patient information for specialty prescriptions is automatically available, but to also prepare for the influx of new specialty treatments. We discuss the electronic solutions for manual processes can address process challenges, such as manual collection and receipt of enrollment data, and prior authorization delays. We discuss the data uncovered in the 2020 specialty pharmacists survey Specialty pharmacists have an incredibly difficult job, given the complex nature of specialty medications and the added burden of a healthcare system disrupted by the COVID-19 pandemic. Yet the ability to touch patients’ lives is what gives meaning to specialty pharmacists’ work. Find more info here: https://surescripts.com/resources/specialty-medications Cecelia Byers, PharmD, Specialty Pharmacy Clinical Product Manager at Surescripts, recently joined the National Association of Specialty Pharmacy Podcast to discuss the challenges that specialty pharmacists face and how technology providers like Surescripts help specialty pharmacists keep the focus on patients. https://surescripts.com/news-center/intelligence-in-action/specialty-medications/podcast-helping-specialty-pharmacists-keep-focus-on-patients See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

This Podcast Series is about Pharmacists & Physicians collaborating on the proper & humane usage of pain managment strategies, the usage of opioids, and evidence-based medication therapy management practices. 
Each day, more than 130 people die from opioid overdoses. Opioids are a class of drugs that include prescription pain relievers like oxycodone. They also include illegal drugs like heroin. In 2019, 1.6 million Americans had an opioid addiction. This is also known as opioid use disorder. Yet effective medications—like buprenorphine, methadone, and naltrexone—are prescribed to only a fraction of people with opioid use disorder.
Patients often receive such medications in an opioid treatment program. Methadone, for example, can only be given in a certified treatment program. Primary care physicians can apply for a waiver to prescribe buprenorphine. However, less than 10% of U.S. primary care providers have a buprenorphine waiver. Given the limited number of patients that each physician can treat, involving pharmacists in opioid treatment may improve access.
Part one features two executives from PROP - Physicians for Responsible Opioid Prescribing to se the stage for the podcast collaborative and helping pharmacists and physicians to work together more effectively through the expertise and experiences of our doctors. 
Today's Guests: 
Jane C. Ballantyne, MD, FRCA
President, PROP
Professor, Anesthesiology and Pain Medicine
University of Washington 
Andrew Kolodny, MD
Vice President, Federal Affairs, PROP;
Medical Director, Opioid Policy Research Collaborative,
Heller School for Social Policy & Management
Brandeis University
Learn more at: http://www.supportprop.org/ 
#PROPRx
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

It's time to rethink how you remain competitive in a digitally transformed marketplace. The Digital Revolution has created a radical paradigm shift in the way the world of business works - are you prepared? 
We are at the beginning of an unprecedented inflection point in the development of civilization—the transition from the first human epoch where centralized hierarchies that leveraged individual intelligence were the basis of social organization to the second human epoch whose social structures will be highly sophisticated distributed networks capable of rapidly leveraging human and artificial collective intelligence. 
Guest speaker is - Rod Collins 
Author & Keynote Speaker and Host of the Salt Flats Innovation Podcast
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

It's the GameChangers' Birthday! This episode is a rapid review of a few subjects to celebrate the first year of GameChangers. From oral iron administration to the use of metronidazole with alcohol or serotonin syndrome, this episode has all the ingredients for a celebration!
GameChangers' host, Geoff Wall, just released new music! Check out his latest EP here: https://open.spotify.com/artist/0J26ngHZz2cf6mQR3UiEHW?827= or wherever you listen to music!
Reference: Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017 Nov;4(11):e524-e533. doi: 10.1016/S2352-3026(17)30182-5. Epub 2017 Oct 9. PMID: 29032957.
Kaundal R, Bhatia P, Jain A, et al. Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia. Ann Hematol. 2020 Jan;99(1):57-63. doi: 10.1007/s00277-019-03871-z. Epub 2019 Dec 6. PMID: 31811360.
Visapää JP, Tillonen JS, Kaihovaara PS, et al. Lack of disulfiram-like reaction with metronidazole and ethanol. Ann Pharmacother. 2002 Jun;36(6):971-4. doi: 10.1345/aph.1A066. PMID: 12022894.
Orlova Y, Rizzoli P, Loder E. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome. JAMA Neurol. 2018 May 1;75(5):566-572. doi: 10.1001/jamaneurol.2017.5144. PMID: 29482205; PMCID: PMC5885255.
CPE details for GameChangers Podcast April 2021
Learning Objective: Discuss the evidence-based dosing of oral iron supplementation.
0107-0000-21-158-H01-P
0.2 CEU/2 Hrs (Knowledge)
Initial Release Date: 04/06/21
Expiration Date: 03/02/24
Additional CPE information is located at https://www.ceimpact.com/podcast 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Queen's Gambit, a Netflix mini-series released in 2020, featured an unlikely cast member alongside Anya Taylor-Joy: Librium, aka Chlordiazepoxide. Uncover the true history of the very first benzodiazepine and join Shane, Mickey and Cal as we analyze the realism of its portrayal in this excellent mini-series.
This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics!
Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com.
PLEASE READ: Shane, Cal and Jill are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health,
A special thanks to Kelly Kerr for creating the music used in the intro and outro.
Additional music from Fesliyan Studios
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The  COVID-19 pandemic exponentially accelerated adoption of virtual care and heightened consumer expectations, which caused health systems to reimagine their role in virtual care. As a result, adoption of virtual care has empowered health systems to move beyond siloed applications to a comprehensive, whole-person approach that consumers will need across their healthcare journey.  
 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Chapter 3 of 3 
Featuring: Allegheny Health Network Pharmacy Services 
Pharmacy Care Continuum
Patient centered care across the patient care continuum…. Starting out as pilots, scaling, and linking
From bedside to the home & community pharmacy integration – reducing costs and limiting readmissions
Guests:
Laura (McCoy) Mark, PharmD - Vice President, Pharmacy
Mike Korczynski, PharmD
Ed Seidl, PharmD - Director of Pharmacy Clinical Services
This podcast series is sponsored by Omnicell. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

"The only way to change the status-quo is to get off your ass and change it." 
Dave Marley, Marley Drug: 
It's not easy but it's possible to fight the 3 largest PBMs in your local community with your pharmacy services. Listen into this podcast & share with other pharmacy owners for several ideas on beating the PBMs in Community Pharmacy. 
Thank you ApproRx & P.U.T.T. for sponsoring this podcast webinar.  
Here's the back-drop information on Marley Drug & Medicure: 
https://www.medicure.com/about 
Work with Medicure today: 
Neal Owens nowens@medicure.com 
IN A RARE MOVE, A DRUG MANUFACTURER WILL BYPASS THE TRADITIONAL APPROACH AND PROVIDE ACCESS TO AFFORDABLE MEDICATIONS ACROSS THE UNITED STATES VIA MARLEY DRUG’S ESTABLISHED MAIL ORDER PHARMACY.  
With licensing to deliver prescription drugs to all 50 states, Washington D.C. and Puerto Rico, and with an established vision to deliver low cost generic medications, Marley Drug Pharmacy was the natural choice for like-minded Canadian drug manufacturer, Medicure Inc., to further expand distribution of its products within the United States, included its branded statin, Zypitamag® (pitavastatin).  
The acquisition allows Medicureto bypass wholesalers and pharmacy benefit managers (PBMs), in an effort to reduce consumer drug costs and provide patients across the U.S. easier access to Zypitamag®, which was extremely difficult for patients and physicians to access because of restrictions and high co-pays dictated by insurers and PBMs. Through Marley Drug Pharmacy, Medicurecan now deliver Zypitamag® to patients in every U.S. state without customers needing to use their insurance, or worry if the prescription will be covered. Medicurecan also provide Zypitamag® at a lower price overall, and a fraction of the cash price of a leading branded statin Livalo® (pitavastatin). As a manufacturer, Medicureintends to provide other branded medications using a similar approach, in addition to extremely low cost generic medications.
“It’s a perfect and responsible transition for Marley Drug,” said Dr. David Marley, CEO & President of Marley Drug. “Medicureshares our moral mission to cut drug costs for consumers. Since 2012 we have offered Marley’s Extended Supply Generic Drug Program, which was designed to battle the skyrocketing costs of name-brand drugs, and offer patients affordable alternatives, without increasing co-pays or limiting access to popular generics.  We worked hard to acquire permits in every state.  Now Medicurecan offer Zypitamag® from coast to coast at a fraction of the cost, without the hassle of PBMs and wholesalers.” 
“Medicure and Marley Drug have the same vision. We want to deliver safe, efficacious and cost-effective medicines that benefit patients and healthcare providers. Our goal is to increase patient access to Zypitamag® while keeping the process and pricing as simple as possible. Through Marley Drug Pharmacy, we can now provide these benefits regardless of insurance or location,” said Dr. Albert Friesen, CEO of Medicure. “There will be no changes to the hours, location or to the great staff and customer service that Marley has built, and look to hire more staff as business grows. Dave Marley will remain a member of the leadership team, and we want Marley Drug to remain a trusted business within the community, and hopefully, this is a game-changing approach that gains attention nationwide.”
Thanks RxSafe for Sponsoring this episode: 
RxSafe.com 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode we are joined by a very special guest, Jill Murphy from Pharmacy Focus Podcast, to discuss some old-timey medical treatments and how they've evolved over time. From the Iron Lung to the Clap, we hope you enjoy these four antiquated medical treatments.
This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics!
Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com.
PLEASE READ: Shane, Cal and Jill are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health,
A special thanks to Kelly Kerr for creating the music used in the intro and outro.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

March Madness inspired us, and our audience has waited long enough. What better time, than during a pandemic, to dive into “OPIOID MADNESS” and crown “The Greatest Opioid of All Time”!!!
In this episode of the “PAIN POD”, Mark “Pain Guy” Garofoli will continue the conversation from Opioid Madness Part 1, the opioid bracketology, or perhaps an “Opioidology”, but definitely a whole bunch of “Opioid Madness”. The battle of poppy versus poppy, and of course a bunch of man-made opioid opponents as well. Cool names and fancy formulations only get one so far, and we simply have no room for bias, thus pharmacology will rule as law of the land, to ultimately crown, “THE GREATEST OPIOID OF ALL TIME”.
The blood thirsty, constipating, yet definitely not sedating championship opioid brawl continues. One opioid, an opioid of all opioids, will remain standing atop the mountain of Mu, declaring its victory over all other opioids from all lands near and far. Which opioid will it be? The PAIN POD crowns the champ!
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Alzheimer's Disease and Related Dementias are a terrible disease on individuals, caregivers, and communities. There are no cures. However, new data has come out discussing the risk factors, polypharmacy, and a potential early detection opportunity. It's time to de-prescribe and follow the money.
Reference: Nicholas LH, Langa KM, Bynum JPW, Hsu JW. Financial Presentation of Alzheimer Disease and Related Dementias. JAMA Intern Med. 2021;181(2):220–227. doi:10.1001/jamainternmed.2020.6432
Maust DT, Strominger J, Kim HM, et al. Prevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US. JAMA. 2021;325(10):952–961. doi:10.1001/jama.2021.1195
CPE details for GameChangers Podcast April 2021
Learning Objective: Discuss if adverse financial outcomes may be a risk factor for future dementia diagnosis.
0107-0000-21-158-H01-P
0.2 CEU/2 Hrs (Knowledge)
Initial Release Date: 04/06/21
Expiration Date: 03/02/24
Additional CPE information is located at https://www.ceimpact.com/podcast 
Disclosure: Dr. Galdo is a member of the Board of Directors for the Alabama Chapter of the Alzheimer's Association.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode 21: Sandra Leal
Sandra Leal, the 166th president of the American Pharmacists Association, was powerfully influenced by her childhood experiences growing up in an Arizona border town – including the pharmacist in nearby Mexico who essentially served as her family’s main health care provider.
In this episode, we talk about those formative experiences, and discuss the twin issues dominating pharmacy today: the pandemic, and structural racism in pharmacy. Recorded April 2, 2021.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Victoria Reinhartz PharmD is an Assistant Professor of Pharmacy Practice at LECOM School of Pharmacy and the Founder & CEO of Mobile Health Consultants, Inc. She also serves as the Consultant Pharmacist for the Manatee County Community Paramedicine Program in Bradenton, FL. Within this role, Dr. Reinhartz and her team resolve medication issues or disease factors which are contributing to frequent 911 use, ER visits, or hospitalization.
Dr. Reinhartz's clinical impact has been recognized with a Chief’s Commendation Award and a Congressional EMS Unit Citation Award for exceptional care provision and leadership within EMS. Dr. Reinhartz has also garnered national attention from the United States Public Health Service for collaborative innovation improving community health outcomes. Most recently, she was named the 2020 Next-Generation Pharmacist Civic Leader, for implementing a vision of interprofessional care that spotlights the needs of underserved communities. She is an advocate of Mobile Integrated Health, Community Paramedicine, and interprofessional collaboration with Emergency Medical Services. 
What public health means to Dr. Reinhartz is embracing interprofessional skillsets to improve access to care, health outcomes, and quality of life for our communities.
Social Media LinkedIn - https://www.linkedin.com/in/victoriareinhartz/
Links Next Generation Pharmacist Awards 2020https://nextgenpharmacist.com/pharmacy-times-and-parata-systems-announce-the-2020-next-generation-pharmacist-winners/ 
Collaboration by emergency medicine pharmacists and prehospital services providers - American Journal of Health-System Pharmacy, Volume 77, Issue 12, 15 June 2020, Pages 918–921
https://academic.oup.com/ajhp/article-abstract/77/12/918/5831519 
EMS World Expo Quick Take: How pharmacists improve EMS patient care - A pharmacist can help EMS improve patient outcomes, participate in protocol development, and collaborate on EMS research projects (Nov 2018) - https://www.ems1.com/pharmacology/articles/ems-world-expo-quick-take-how-pharmacists-improve-ems-patient-care-ZcojQQ56JiCN5GfY/
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Chapter 2 of 3 
Featuring: Allegheny Health Network Pharmacy Services 
Medication Safety
Technology
Pharmacist/ Technician roles
Education and training
Guests:
Laura (McCoy) Mark, PharmD - Vice President, Pharmacy
Kimberly (Miller) Mehta, PharmD, MPH, MHA - Pharmacy Director of Medication Safety and Regulatory 
Rich Kaplan, PharmD 
This podcast series is sponsored by Omnicell. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, we are joined by Dr. Jordan Smith, Assistant Professor of Clinical Sciences at High Point University and our go-to expert for questions on infectious diseases. We'll discuss the rumors of infertility associated with the mRNA COVID-19 vaccine, and any possible long-term effects of getting vaccinated. This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics!
Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com.
PLEASE READ: Shane and Cal are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health,A special thanks to Kelly Kerr for creating the music used in the intro and outro.
Additional music by FesliyanStudiosAll Rights Reserved
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

LIPA v ESI: Fight for the Right to Be Paid 
What happens when a state implements provider fee statutes that are officially approved by CMS but one of the big 3 PBMs still claims exemption?
Join guest host Monique Whitney with special guests Randal Johnson, JR Whaley, and MJ Terrebonne as they discuss Louisiana's legal battle with ESI over 10 cents per claim, and the ramifications this could have on state Medicaid programs nationwide.
Host: 
Monique Whitney, Executive Director, Pharmacists United for Truth & Transparency 
Guests:  
Randal Johnson, CEO, Louisiana Independent Pharmacies Association 
JR Whaley, Legal Counsel, Louisiana Independent Pharmacies Association 
MJ Terrebonne, Health Policy Expert & retired Director of Pharmacy, Louisiana Medicaid
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Learn how health systems can leverage a vibrant, pharmacy-finance partnership to drive successful 340B programs, and allow pharmacy staff more time to focus on patient care. Find out why 340B program management has evolved, the program challenges that health systems still face, and the data and operational complexities that necessitate a cross-functional approach.
Guests:                     
Eric Iorfido, PharmD, 340B Program Manager, Penn Highlands DuBois, PA
Charles Hirner, RPh, Senior Director, Omnicell 340B Operations
Host:                         
Ken Perez, Vice President, Healthcare Policy and Government Affairs, Omnicell
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Tennessee Gov. Bill Lee signed HB 786, a comprehensive PBM reform bill that strengthens existing fair pharmacy audit laws, limits PBM adjudication fees, and prohibits a PBM from reimbursing a pharmacy less than it reimburses a PBM-affiliated pharmacy.May 30, 2019
Tennessee SB650
Present law defines "pharmacy benefits manager" (PBM) to mean a person, business, or other entity and any wholly or partially owned subsidiary of the entity, that administers the medication and/or device portion of pharmacy benefits coverage provided by a health insurance plan, subject to certain exceptions.
Present law provides detailed requirements for the conduct of an audit of records of a pharmacist or pharmacy by a health insurance plan, a PBM, the state or its political subdivisions, or any other entity representing the same. One such audit requirement is that a clerical or recordkeeping error regarding a required document or record may not, in and of itself, constitute fraud; however, the claims may be subject to recoupment. This bill instead provides that a clerical or recordkeeping error identified during an audit is not prima facie evidence of fraud or intentional misrepresentation and must not be the basis of a recoupment unless the error results in an actual overpayment to the pharmacy or the wrong medication being dispensed to the patient. As under present law, a clerical error will not be subject to criminal penalties without proof of intent to commit fraud. 
Shane Reeves is an American businessman, pharmacist and politician who is the State Senator for the 14th District of Tennessee, which is composed of Bedford County, Moore County, Lincoln County, Marshall County, and part of Rutherford County. As a seventh-generation Tennessean, Senator Shane Reeves has spent his life raising a family and opening businesses in middle Tennessee. He understands the importance of family, character, and conservative values to the people in this community.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

More and more vaccines are getting authorization in the United States to prevent COVID-19. However, sometimes a vaccine trial is not always effective. But even failure can provide new insights. Learn about the Janssen COVID-19 vaccine and what happened with the recent Hepatitis C vaccine candidate.
This podcast was recorded prior to the joint CDC and FDA statement on the Johnson & Johnson/Janssen COVID-19 vaccine on April 13th. On April 13th, 2021, the CDC and FDA issued a joint statement recommending a pause on the use of the Johnson & Johnson/Janssen COVID-19 vaccine until further notice. Click here for the full statement.
Reference: Page K, Melia M, Veenhuis R, et al. Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection. N Engl J Med 2021; 384:541-549. DOI: 10.1056/NEJMoa2023345
Fact Sheet for Healthcare Providers Administering Vaccine Emergency Use Authorization of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019. https://www.fda.gov/media/146304/download 
CPE details for GameChangers Podcast April 2021
Learning Objective: Describe the outcomes of a recently published trial on hepatitis C vaccine candidates.
0107-0000-21-158-H01-P
0.2 CEU/2 Hrs (Knowledge)
Initial Release Date: 04/06/21
Expiration Date: 03/02/24
Additional CPE information is located at https://www.ceimpact.com/podcast 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices